|
PIGS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.348200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.035190E-01 |
| Normal-vs-Stage2 |
2.010200E-01 |
| Normal-vs-Stage3 |
2.069200E-01 |
| Normal-vs-Stage4 |
1.037840E-01 |
| Stage1-vs-Stage2 |
7.943600E-01 |
| Stage1-vs-Stage3 |
7.853600E-01 |
| Stage1-vs-Stage4 |
2.383400E-01 |
| Stage2-vs-Stage3 |
9.849200E-01 |
| Stage2-vs-Stage4 |
3.385000E-01 |
| Stage3-vs-Stage4 |
3.477600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.056020E-01 |
| Normal-vs-AfricanAmerican |
7.812100E-02 |
| Normal-vs-Asian |
2.315200E-01 |
| Caucasian-vs-AfricanAmerican |
6.173000E-01 |
| Caucasian-vs-Asian |
5.266400E-01 |
| AfricanAmerican-vs-Asian |
6.042600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.019500E-02 |
| Normal-vs-Female |
8.106400E-01 |
| Male-vs-Female |
1.485750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.623100E-03 |
| Normal-vs-Extreme_Weight |
3.949800E-02 |
| Normal-vs-Obese |
2.464200E-01 |
| Normal-vs-Extreme_Obese |
9.143000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.945000E-01 |
| Normal_Weight-vs-Obese |
6.091700E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.251800E-01 |
| Extreme_Weight-vs-Obese |
4.111000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.012200E-01 |
| Obese-vs-Extreme_Obese |
8.166000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.957600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.178800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.156300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.53837999999906E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.251200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.591800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.435100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.254000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.429000E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.101900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.391400E-01 |
| Normal-VS-Type2 PRCC |
1.220110E-02 |
| Normal-VS-KIRP CIMP |
5.405000E-01 |
| Normal-VS-Unclassified PRCC |
6.763200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.441700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.076800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.205800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.023200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.939800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.804800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.752300E-02 |
| Normal-vs-N1 |
2.153000E-01 |
| Normal-vs-N2 |
7.747600E-01 |
| N0-vs-N1 |
8.666600E-01 |
| N0-vs-N2 |
7.714600E-01 |
| N1-vs-N2 |
8.665600E-01 |
|
|
